TETRACYCLINE Drug Patent Profile
✉ Email this page to a colleague
When do Tetracycline patents expire, and what generic alternatives are available?
Tetracycline is a drug marketed by Abbott, Amneal Pharms Ny, Ani Pharms, Aurobindo Pharma Usa, Breckenridge, Chartwell Tetra, Elkins Sinn, Ferrante, Heather, Hikma, Impax Labs, Ivax Sub Teva Pharms, Mast Mm, Novitium Pharma, Purepac Pharm, Pvt Form, Roxane, Sun Pharm Industries, Superpharm, Valeant Pharm Intl, Warner Chilcott, Watson Labs, Wyeth Ayerst, Alpharma Us Pharms, and Proter. and is included in twenty-nine NDAs.
The generic ingredient in TETRACYCLINE is tetracycline hydrochloride. There are ninety-nine drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the tetracycline hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tetracycline
A generic version of TETRACYCLINE was approved as tetracycline hydrochloride by WATSON LABS on December 31st, 1969.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TETRACYCLINE?
- What are the global sales for TETRACYCLINE?
- What is Average Wholesale Price for TETRACYCLINE?
Summary for TETRACYCLINE
| US Patents: | 0 |
| Applicants: | 25 |
| NDAs: | 29 |
| Drug Prices: | Drug price information for TETRACYCLINE |
| DailyMed Link: | TETRACYCLINE at DailyMed |



